PubMed · 2012 · 15 citations · 13 references
MedicineOncologyPharmacologyChemotherapyClinical PharmacologyOncology PharmacotherapyAdverse Effects Of ChemotherapyChemotherapy Drug AdministrationChemotherapy Toxicity ManagementPancreatic CancerPancreatic DiseasesPancreatic DisordersCapecitabine-based TherapyDrug-induced Hand-foot SyndromeHand-foot Syndrome ManagementHyperlipidemic PancreatitisNecrotizing PancreatitisPancreatic Cancer PharmacotherapyPancreatitis RiskSide Effect Profile
Capecitabine is an orally administered pro-drug of 5-fluorouracil that confers superior disease-free survival and presumably has a more favourable side-effect profile. Here we report on a patient who developed acute necrotising pancreatitis and very high triglyceride levels as well as hand-foot syndrome after receiving capecitabine for colonic cancer. Increased awareness of this potential side-effect and close monitoring of lipid levels may be warranted, especially in patients who have other conditions predisposing them to severe secondary hyperlipidaemia when using this drug.
13
John W. Devlin, Adah K. Lau, Maged Tanios · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2005 · 159 citations
Capecitabine-Induced Severe Hypertriglyceridemia: Report of Two Cases
Mevlüt Kurt, Melih O. Babaoğlu, Ümit Yaşar et al. · Annals of Pharmacotherapy · 2006 · 37 citations
Pharmacy, Oncology, Pharmacology +17